(866) 744-0454 Call us Start 2-minute check

Labs

Hematocrit on TRT: What It Means and How Providers Lower It

Why testosterone therapy can raise hematocrit, the guideline thresholds providers watch, and how they decide whether to lower hematocrit on TRT.

Written by Branden Staller, MD

  • Last updated
  • 8 min read
  • Copy link
On this page
A gloved hand places an empty blood tube with a lavender cap into a white rack on a clinic counter

The short answer

Testosterone therapy raises hematocrit, the share of your blood made up of red blood cells, and in some men it rises too high. Whether and how to lower hematocrit on TRT is a decision for your provider. The Endocrine Society guideline calls for checks before treatment and at set times afterward, and for pausing therapy when the level is too high.

Key takeaways

  • Testosterone raises hematocrit. Too many red blood cells (erythrocytosis) is the most frequent side effect reported in randomized trials of testosterone.
  • The Endocrine Society's 2018 guideline advises stopping testosterone if hematocrit goes above 54%, then restarting at a lower dose once it falls.
  • The FDA labels reviewed here give no numeric cutoff. Several say to stop therapy when hematocrit is elevated until it drops to an acceptable level.
  • The guideline recommends checking hematocrit before treatment, at 3 to 6 months, then yearly. Label schedules differ by product.
  • Leg pain, swelling or redness, chest pain or trouble breathing can signal a blood clot. Call your healthcare provider right away.

What is hematocrit, and why does testosterone affect it?

Hematocrit is a blood test that measures what percent of your blood is made up of red blood cells1. Testosterone raises it. The Endocrine Society's 2018 guideline says testosterone increases hemoglobin and hematocrit, and that the size of the effect depends on the dose and on testosterone levels in the blood2.

When the count climbs too high, the condition is called erythrocytosis, or polycythemia: there are too many red blood cells and the blood becomes too thick1. The guideline defines testosterone-related erythrocytosis as a hematocrit above 54%2. It is the most frequent adverse event reported in randomized trials of testosterone2,3, and both the rise in hematocrit and the rate of erythrocytosis are higher in older men than in young men2.

Why it happens is still being studied. In one trial, older men with mobility limitation were randomly assigned to testosterone or placebo for six months3. In the men on testosterone, the rise in hemoglobin and hematocrit came with higher erythropoietin (EPO) levels and lower levels of two iron-related markers, ferritin and hepcidin3. Based on this trial, the researchers proposed that testosterone stimulates red blood cell production by raising EPO, by resetting the EPO level the body aims for relative to its hemoglobin, and by increasing the use of iron3.

What hematocrit level is too high on TRT?

No single number applies to every man or every lab. The Endocrine Society's 2018 guideline advises stopping testosterone if hematocrit rises above 54% during treatment, until it falls2. The FDA testosterone labels reviewed here do not give a number. Several say that if hematocrit becomes elevated, therapy should stop until it decreases to an acceptable level4,5,6.

The guideline uses a lower level before treatment begins. It treats a baseline hematocrit above 48%, or above 50% for men who live at high altitude, as a relative contraindication, because these men are more likely to go above 54% on testosterone2. The guideline treats this as a reason for caution and discussion: when a man's baseline is above his lab's upper limit of normal, the guideline says the clinician should discuss the higher risk of erythrocytosis and the need for close monitoring before giving testosterone2. Several FDA labels say to check hematocrit, or confirm it is not elevated, before treatment starts4,5,6.

Your own result should be read against the reference range your lab prints. Normal hematocrit levels vary with sex, age, smoking and the altitude where you live1.

Why a high hematocrit matters

Several FDA testosterone labels say an increase in red blood cell mass may increase the risk of thromboembolic events, meaning blood clots4,5,6. The guideline adds that the hematocrit level at which the risk of neuro-occlusive or cardiovascular events goes up is not known2. It also says the frequency of neuro-occlusive events among trial participants who developed erythrocytosis has been very low2.

Important safety information

Testosterone is FDA-approved for men with low testosterone caused by certain medical conditions. Its safety and effectiveness for low testosterone due to aging alone have not been established. Testosterone can raise blood pressure and red blood cell count, reduce sperm production and fertility, and requires monitoring of the prostate and blood levels. Your provider will review the benefits and risks and monitor you with regular labs.

Testosterone is a controlled substance because it can be misused. Abuse and dependence have been reported, mostly at doses above those prescribed. Take it only as your provider directs.

Read the full Important Safety Information for testosterone

How often is hematocrit checked on TRT?

The Endocrine Society's 2018 guideline recommends measuring hematocrit before treatment, again at 3 to 6 months after starting, and then once a year2. FDA testosterone labels differ by product. Some say to evaluate hematocrit approximately every 3 months during treatment5,6. Another says to recheck it 3 to 6 months after starting and then annually4. An older-format label says only that hemoglobin and hematocrit should be checked periodically during long-term use7.

These label instructions come from revisions dated July through October 2025, as shown on DailyMed on November 2, 20264,5,6,7. In June 2026, FDA requested updates to testosterone prescribing information after reviewing new data, including the TRAVERSE trial8. As of November 2, 2026, those are requested changes and not yet approved labeling, so the label wording quoted here may change8.

Hematocrit is one part of routine blood work during treatment. Our page on follow-up labs during testosterone therapy covers the rest of that schedule, and TRT safety and monitoring explains how monitoring fits into care.

Want your levels checked properly?

The 2-minute check asks your state first. A care coordinator then calls you to set up a morning draw and a visit with a licensed provider.

Start 2-minute checkFind an office

Prescription treatment requires an evaluation by a licensed healthcare provider, who decides whether treatment is appropriate for you. Not everyone qualifies. Completing an assessment, booking a visit, or paying a fee does not guarantee a prescription.

What else causes high hematocrit on TRT?

Testosterone may not be the only reason for a high result. MedlinePlus names dehydration as the most common cause of a high hematocrit1. It also lists lung disease, congenital heart disease, heart failure, polycythemia and living at high altitude, where the air has less oxygen1. The Endocrine Society guideline tells clinicians to evaluate a man whose hematocrit rises above 54% on testosterone for hypoxia (low oxygen) and sleep apnea2.

Dehydration raises the reading because it lowers the plasma, the liquid part of the blood1. Sleep apnea matters before treatment too: the guideline recommends against starting testosterone in men with untreated severe obstructive sleep apnea or an elevated hematocrit2. For these reasons a provider may ask about your sleep, your breathing, any heart or lung conditions and where you live before deciding what a high number means.

How do providers lower hematocrit on TRT?

Lowering hematocrit on TRT is a decision your provider makes with you. The Endocrine Society guideline describes the main steps: look for other causes, hold testosterone until the level falls, and restart at a lower dose2. Do not change your dose, stop treatment or start any medicine, supplement or procedure on your own.

Confirming the result

A single high reading may need context. MedlinePlus notes that a result outside the normal range doesn't always mean you have a condition that needs treatment1. Because dehydration can push the number up1, a provider may repeat the test before acting on it.

Reviewing the dose and schedule

The guideline says testosterone's effect on hematocrit is related to the dose and to blood testosterone levels2. Some FDA labels say a rise in hematocrit may require lowering the dose or stopping testosterone4,5. A provider may review your dose and schedule against your labs.

Evaluating other causes

The guideline calls for evaluating hypoxia and sleep apnea in men who develop a high hematocrit on testosterone2. If the provider finds another possible cause, such as one of the conditions listed above1, they may evaluate it further or refer you.

Holding therapy

If hematocrit is above 54%, the guideline advises stopping testosterone until hematocrit returns to the normal range, then restarting at a reduced dose2. Several FDA labels say to stop therapy until hematocrit decreases to an acceptable level4,5,6. Two of them add that if hematocrit becomes elevated again after a restart, that product should be stopped permanently5,6.

Therapeutic phlebotomy

The guideline says using therapeutic phlebotomy to lower hematocrit is also effective for erythrocytosis caused by testosterone treatment2. It is an option a treating provider may order.

What this means for you: when to see a clinician

If you take testosterone, keep your scheduled blood tests and ask for your hematocrit result along with your lab's reference range. If the result is high, call your provider before you change anything; the dose, the schedule and any next step are your provider's decisions.

It helps to tell your provider:

  • whether you have sleep apnea or are being treated for it, since the guideline calls for evaluating sleep apnea2
  • about any lung or heart condition, and whether you live at high altitude1
  • if you were unwell or not drinking much before the blood draw, because dehydration can raise hematocrit1

Call your healthcare provider right away if you have leg pain, swelling or redness, which can be signs of a blood clot in the leg, or difficulty breathing or chest pain, which can be signs of a blood clot in the lungs4. If symptoms are sudden or severe, seek emergency care.

The guideline also cites case reports suggesting that clot risk may be higher in men with thrombophilia, a tendency to form blood clots, even without a raised hematocrit, especially within the first 6 months after starting testosterone2. Case reports alone cannot establish that, so report clot symptoms whatever your last hematocrit was.

Talk it through with a coordinator

A coordinator explains each step and its cost before you pay, and books your labs. A licensed provider then goes through your results with you.

Start 2-minute checkFind an office

Prescription treatment requires an evaluation by a licensed healthcare provider, who decides whether treatment is appropriate for you. Not everyone qualifies. Completing an assessment, booking a visit, or paying a fee does not guarantee a prescription.

Questions

Does TRT raise hematocrit?

Yes. The Endocrine Society guideline says testosterone raises hemoglobin and hematocrit, and that in some men it causes erythrocytosis, defined there as a hematocrit above 54%2. The guideline also recommends checking hematocrit before and during treatment2.

Will stopping TRT lower hematocrit?

The guideline and several FDA labels describe stopping therapy until hematocrit comes down2,4,5,6. Whether to do that is your provider's decision, made with your result and other possible causes in view, so call your provider about a high result instead of stopping on your own.

Will lowering the TRT dose lower hematocrit?

The guideline ties the rise to dose and blood testosterone levels and advises restarting at a lower dose after a pause2. Some FDA labels say a rise in hematocrit may require lowering the dose or stopping testosterone4,5.

How much does TRT raise hematocrit?

It differs from man to man. The guideline says the rise depends on the testosterone dose and on testosterone levels in the blood, and that it is larger in older men than in young men2. The guideline recommends checking hematocrit before and during treatment2.

Sources

  1. Hematocrit Test. MedlinePlus, National Library of Medicine (NIH). Accessed 2026-11-02. medlineplus.gov/lab-tests/hematocrit-test/
  2. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline (Bhasin et al., JCEM 2018;103(5):1715-1744). Endocrine Society / The Journal of Clinical Endocrinology & Metabolism. Accessed 2026-11-02. academic.oup.com/jcem/article/103/5/1715/4939465
  3. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point (Bachman et al., J Gerontol A Biol Sci Med Sci 2014). The Journals of Gerontology, Series A (via PubMed Central). Accessed 2026-11-02. pmc.ncbi.nlm.nih.gov/articles/PMC4022090/
  4. ANDROGEL (testosterone) gel - prescribing information. U.S. FDA label via DailyMed (NLM). Accessed 2026-11-02. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4e8d29b-8707-4d47-e053-2a95a90aecee
  5. JATENZO (testosterone undecanoate) capsules - prescribing information. U.S. FDA label via DailyMed (NLM). Accessed 2026-11-02. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed7b5d41-7475-4c10-99b9-b62b3434ae60
  6. XYOSTED (testosterone enanthate) injection - prescribing information. U.S. FDA label via DailyMed (NLM). Accessed 2026-11-02. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8a3d204c-be26-49e0-8599-0ac12a272e81
  7. DEPO-TESTOSTERONE (testosterone cypionate) injection - prescribing information. U.S. FDA label via DailyMed (NLM). Accessed 2026-11-02. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cfbb53d4-b868-4a28-8436-f9112eb01c39
  8. Testosterone Information | FDA. U.S. Food and Drug Administration. Accessed 2026-11-02. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/testosterone-information

Share this guide

Copy link

Important Safety Information: testosterone

Testosterone is a Schedule III controlled substance. Depending on your state, and on federal telemedicine rules that are currently set to change after December 31, 2026, an in-person exam may be required before or during treatment.

Prescription treatment requires an evaluation by a licensed healthcare provider, who decides whether treatment is appropriate for you. Not everyone qualifies. Completing an assessment, booking a visit, or paying a fee does not guarantee a prescription.

This article is general health information and not medical advice. It does not replace a visit with a licensed clinician. If you have a medical emergency, call 911.

Our editorial team writes guides from the sources listed; medical review by a licensed clinician will be added when our providers join the site. Editorial policy. Spotted an error? Tell our editors.

Back to top
Start 2-minute check Call